Alliance Cancer Control Program Pilot Project Award Specific to Eliminating InEquities and Delivering Optimal Care

The Alliance offers funds ($100,000 in total costs) to support early stage investigators (ESI) and clinical investigators and pilot projects in the Cancer Control Program (CCP). Priority is given to ESIs from diverse backgrounds and projects addressing clinical trial issues related to underrepresented populations. Projects may address cancer prevention, risk assessment, screening, symptom intervention, surveillance, health outcomes research, or specific population groups, especially minority and underserved, older adult, or adolescent and young adult populations. The purpose of these pilot projects is to generate preliminary data that will lead to Alliance protocols. Eligible proposals must address at least one of the following categories and must include a research project:

  1. Underrepresented early stage clinical investigator who self-identifies as Black/African American, Hispanic/Latino, Native Hawaiian or other Pacific Islander or American Indian and whose research proposal focuses on cancer prevention and control.
  2. Clinical investigator whose research proposal focuses on underrepresented populations (URPs), including those who are racially, ethnically, and age (both young and older) diverse, or belong to a sexual minority.

The recipient for the 2024 CCP Pilot Project Award is Kinsey Pebley, PhD, MPH, of Medical University of South Carolina, mentored by Alana Rojewski, PhD -
project: “Video Interventions for Dependence on Smoke (VIDeOS) for Cancer Patients Prevention and Health Outcomes Committees.”

For more information about the CCP Pilot Project Award, please contact Jill Oliveri, DrPH, at jill.oliveri@osumc.edu or 614-293-8174.